Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Focus

PDF

Screening e malattia celiaca

CELIAC DISEASE AND SCREENING

T. Not

Settembre 2005 - pagg. 449 -455

Abstract
From the clinical and the epidemiological point of view, celiac disease may represent an appropriate disease model to apply a population based screening strategy. In the literature, the use of human tTG antibodies is described as an efficient screening strategy both in high risk groups and in family “case finding” series. However, population based screening is still a matter of debate, since it is yet not clear which is the most appropriate age when performing the screening and which motivations to offer to those subjects positive at the screening but still asymptomatic. It has been suggested to first identify subjects at risk by neonatal determination of HLA DQ2/DQ8 and to follow them up with periodical sierological tTG tests in order to identify early celiac patients.

Bibliografia

1. Fasano A. European and North American populations should be screened for coeliac disease. Gut 2003;52:168-9.
2. Hin H, Bird G, Fisher P, Mahy N, Jewell D. Coeliac disease in primary care: case finding study. BMJ 1999;318:164-7.
3. Ventura A, Facchini S, Amantidu S, et al. Searching for celiac disease in pediatric general practice. Clin Pediatr 2001;40:575-7.
4. Young EH, Wareham NJ. Screening for coeliac disease: what evidence is required before population programmes could be considered. Arch Dis Child 2004;89:499- 501.
5. Hoffenberg EJ, MacKenzie T, Barriga KJ, et al. A prospective study of the incidence of childhood celiac disease. J Pediatr 2003; 143:308-14.
6. Mustalahti K, Lohiniemi S, Collin P, et al. Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract 2002;5:105-13.